Renagel - Sevelamer hydrochloride

Burke S, Amin N, Incerti C, Plone M, Watson N. Sevelamer hydrochloride (Renagel), a nonabsorbed phosphate-binding polymer, does not interfere with digoxin or warfarin pharmacokinetics. J Clin Pharmacol 2001 41(2) 193-8. [Pg.674]

Burke SK, et al. Sevelamer hydrochloride (Renagel), a phosphatebinding polymer, does not alter the pharmacokinetics of two commonly used antihypertensives in healthy volunteers. J CUn Pharmacol 2001 41 199-205. [Pg.849]

Renagel Capsules (Sevelamer hydrochloride). Genome. US Prescribii information, April... [Pg.447]

After successful multiphase chnical trials as the first metal-free phosphate sequestrant for the treatment of hyperphosphatemia, polymer Scheme 6 was approved in the United States by the FDA in 1998 under the generic name of sevelamer hydrochloride. It has been marketed since under the brand name Renagel by Genzyme Corporation. [Pg.21]

Big Chemical Encyclopedia